This inventor holds 1 USPTO granted patent. Top assignee: Xiamen University. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Jiaji Zhong: Innovator in Pharmaceutical Compounds
Introduction
Jiaji Zhong is a notable inventor based in Xiamen, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating tumors. His work is characterized by a focus on innovative chemical formulations and their applications in medicine.
Latest Patents
Jiaji Zhong holds a patent for a substituted aryl ether compound, which includes a preparation method, pharmaceutical composition, and its use in the manufacture of a medicament for preventing or treating tumors. The patent details a compound with a specific formula, including its stereoisomers, prodrugs, pharmaceutically acceptable salts, and solvates. This invention represents a significant advancement in the pharmaceutical industry, providing new avenues for cancer treatment.
Career Highlights
Zhong is affiliated with Xiamen University, where he conducts research and development in the field of medicinal chemistry. His academic background and research endeavors have positioned him as a key figure in the innovation of pharmaceutical compounds. His work not only contributes to scientific knowledge but also has practical implications for patient care.
Collaborations
Jiaji Zhong collaborates with esteemed colleagues such as Xianming Deng and Ting Zhang. These partnerships enhance the research output and foster a collaborative environment that drives innovation in their respective fields.
Conclusion
Jiaji Zhong's contributions to pharmaceutical innovation, particularly through his patented work, underscore his role as a significant inventor in the industry. His research continues to pave the way for advancements in cancer treatment and pharmaceutical development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile